Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting.

Merkoudis N, Granstam E.

Eur J Ophthalmol. 2013 Jul-Aug;23(4):558-63. doi: 10.5301/ejo.5000261. Epub 2013 Mar 6.

PMID:
23483492
[PubMed - indexed for MEDLINE]
Free Article
2.

SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.

Coscas G, Coscas F, Zucchiatti I, Glacet-Bernard A, Soubrane G, Souïed E.

Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.

PMID:
21500185
[PubMed - indexed for MEDLINE]
3.

[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].

Brunner M, Haueter I, Valmaggia C.

Klin Monbl Augenheilkd. 2013 Apr;230(4):396-400. doi: 10.1055/s-0032-1328365. Epub 2013 Apr 29. German.

PMID:
23629790
[PubMed - indexed for MEDLINE]
4.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J.

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.

PMID:
21764136
[PubMed - indexed for MEDLINE]
5.

Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.

Ferrini W, Ambresin A.

Klin Monbl Augenheilkd. 2013 Apr;230(4):423-6. doi: 10.1055/s-0032-1328388. Epub 2013 Apr 29.

PMID:
23629796
[PubMed - indexed for MEDLINE]
6.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.

PMID:
20417567
[PubMed - indexed for MEDLINE]
7.

Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.

Bezatis A, Spital G, Höhn F, Maier M, Clemens CR, Wachtlin J, Lehmann F, Hattenbach LO, Feltgen N, Meyer CH.

Acta Ophthalmol. 2013 Aug;91(5):e340-7. doi: 10.1111/aos.12020. Epub 2013 May 3.

PMID:
23638803
[PubMed - indexed for MEDLINE]
8.

Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.

Meyer LM, Schönfeld CL.

J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):560-5. doi: 10.1089/jop.2012.0253. Epub 2013 Mar 12.

PMID:
23480270
[PubMed - indexed for MEDLINE]
9.

Changes in macular function after ozurdex for retinal vein occlusion.

Querques G, Cascavilla ML, Cavallero E, Triolo G, Querques L, Lattanzio R, Cicinelli MV, Preziosa C, Borrelli E, Bandello F.

Optom Vis Sci. 2014 Jul;91(7):760-8. doi: 10.1097/OPX.0000000000000308.

PMID:
24927143
[PubMed - indexed for MEDLINE]
10.

Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.

Yeh WS, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P, Whitcup SM, Kowalski JW.

Ophthalmology. 2012 Jun;119(6):1190-8. doi: 10.1016/j.ophtha.2011.12.028. Epub 2012 Feb 22.

PMID:
22361318
[PubMed - indexed for MEDLINE]
11.

Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.

Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.

Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1.

PMID:
18327140
[PubMed - indexed for MEDLINE]
12.

[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].

Saleh M, Gaucher D, Letsch J, Bourcier T, Speeg-Schatz C.

J Fr Ophtalmol. 2011 Jun;34(6):355-61. doi: 10.1016/j.jfo.2011.04.008. Epub 2011 Jun 8. French.

PMID:
21652108
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

PMID:
22739239
[PubMed - indexed for MEDLINE]
14.

Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.

Pichi F, Specchia C, Vitale L, Lembo A, Morara M, Veronese C, Ciardella AP, Nucci P.

Am J Ophthalmol. 2014 Mar;157(3):607-15.e1. doi: 10.1016/j.ajo.2013.11.016. Epub 2013 Nov 27.

PMID:
24528934
[PubMed - indexed for MEDLINE]
15.

Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).

Capone A Jr, Singer MA, Dodwell DG, Dreyer RF, Oh KT, Roth DB, Walt JG, Scott LC, Hollander DA.

Retina. 2014 Feb;34(2):342-51. doi: 10.1097/IAE.0b013e318297f842.

PMID:
23846381
[PubMed - indexed for MEDLINE]
16.

Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.

Adán A, Pelegrín L, Rey A, Llorenç V, Mesquida M, Molins B, Ríos J, Keller J.

Retina. 2013 Jul-Aug;33(7):1435-40. doi: 10.1097/IAE.0b013e31827e247b.

PMID:
23514796
[PubMed - indexed for MEDLINE]
17.

Comparative effectiveness of the dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to central retinal vein occlusion.

Shaikh AH, Petersen MR, Sisk RA, Foster RE, Riemann CD, Miller DM.

Ophthalmic Surg Lasers Imaging Retina. 2013 Jan-Feb;44(1):28-33. doi: 10.3928/23258160-20121221-09.

PMID:
23418731
[PubMed - indexed for MEDLINE]
18.

Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.

Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, Corradetti G, Cascavilla ML, Bandello F.

Ophthalmologica. 2013;229(1):21-5. doi: 10.1159/000342160. Epub 2012 Sep 19.

PMID:
23006995
[PubMed - indexed for MEDLINE]
19.

Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.

Querques G, Lattanzio R, Querques L, Triolo G, Cascavilla ML, Cavallero E, Del Turco C, Casalino G, Bandello F.

Retina. 2014 Feb;34(2):330-41. doi: 10.1097/IAE.0b013e31829f7495.

PMID:
23945638
[PubMed - indexed for MEDLINE]
20.

Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion.

Parodi MB, Iacono P, De Benedetto U, Cascavilla M, Bandello F.

J Ocul Pharmacol Ther. 2012 Dec;28(6):566-8. doi: 10.1089/jop.2012.0016. Epub 2012 Jul 2.

PMID:
22746671
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk